Related Articles
Characterization of a prognostic four‑gene methylation signature associated with radiotherapy for head and neck squamous cell carcinoma
Experimental study of the anti-cancer mechanism of tanshinone IIA against human breast cancer
SENP1 inhibits ferroptosis and promotes head and neck squamous cell carcinoma by regulating ACSL4 protein stability via SUMO1
Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway
Tanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injury